Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1 / FLT3 -ITD Genotypes in Patients with Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 8914–8916.

https://doi.org/10.1182/blood-2022-158686

Published: 2022

Journal Articles

Late Relapse After Allogeneic Hematopoietic Cell Transplantation For Hematological Malignancies: A Nationwide Retrospective Study From The Late Complications and Quality-Of-Life Working Group Of The Japan Society For Hematopoietic Cell Transplantation

Takuya Yamashita, MD, PhD, Hideyuki Kuwabara, MD, Kazuteru Ohashi, MD, FACP, Naoyuki Uchida, MD, PhD, Takahiro Fukuda, MD, Koichi Miyamura, MD, PhD, Shin-ichiro Mori, MD, PhD, Koji Kato, MD, PhD, Junji Tanaka, MD, PhD, Souichi Adachi, MD, PhD, Yoshiko Atsuta, MD

Blood (2013) 122 (21): 4630.

https://doi.org/10.1182/blood.V122.21.4630.4630

Published: 2013

Journal Articles

Pharmacokinetics for Once-Daily Modified Release Formulation Tacrolimus Hydrate in Unrelated Hematopoietic Stem Cell Transplantation.

Shingo Yano, MD, Shin-ichiro Mori, Takeshi Saito, MD, Hiroki Yokoyama, MD, Tomohito Machishima, Katsuki Sugiyama, MD, Yoji Ogasawara, MD, PhD, Kinuyo Kasama, MD, Noriko Usui, MD, Keisuke Aiba, MD, PhD, Takuya Yamashita, MD

Blood (2012) 120 (21): 3048.

https://doi.org/10.1182/blood.V120.21.3048.3048

Published: 2012

Journal Articles

Immunochromatography Method Was Useful in Prompt Diagnosis of Potentially Fatal Norovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation

Ryosuke Ueda, MD, Nobuhiro Hiramoto, MD, Shin-Ichiro Mori, MD, Saiko Kurosawa, MD, Takashi Tanaka, MD, Kohei Tada, MD, Yujin Kobayashi, MD, Noriyuki Morikawa, MD, Akihito Shinohara, MD, Keiji Okinaka, MD, Takuya Yamashita, MD, Yuji Heike, MD, Takahiro Fukuda, MD

Blood (2011) 118 (21): 4542.

https://doi.org/10.1182/blood.V118.21.4542.4542

Published: 2011

Journal Articles

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

Nobuhiro Hiramoto, MD, Kinuko Tajima, Saiko Kurosawa, MD, Takuya Yamashita, MD, Kenji Okinaka, MD, Noriyuki Morikawa, MD, Kohei Tada, MD, Takashi Tanaka, MD, Ryosuke Ueda, MD, Yujin Kobayashi, MD, Akihito Shinohara, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Yuji Heike, MD, Takahiro Fukuda, MD

Blood (2011) 118 (21): 2033.

https://doi.org/10.1182/blood.V118.21.2033.2033

Published: 2011

Journal Articles

A Novel Enumeration Method for Hematopoietic Progenitor Cells in Collecting Peripheral Blood Stem Cell for Transplantation

Ryuji Tanosaki, M.D., Tomoko Kumazawa, M.T., Shigehisa Yoshida, M.T., Atsuya Nakano, M.T., Shizuka Yamagata, M.T., Noriko Takahashi, M.T., Saiko Kurosawa, MD, Shin-Ichiro Mori, M.D., Yuji Heike, MD, Takahiro Fukuda, MD, Ko Furuta, M.D., Hitoshi Tsuda, M.D.

Blood (2011) 118 (21): 1922.

https://doi.org/10.1182/blood.V118.21.1922.1922

Published: 2011

Journal Articles

Engraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk Patients

Takeshi Maeda, MD, Kimikazu Yakushijin, MD, Yoshitaka Asakura, MD, Nobuhiro Hiramoto, MD, Saiko Kurosawa, MD, Yutaro Kamiyama, MD, Suguru Fukuhara, MD, Niina Ueno, MD, Sung-Won Kim, MD, Shin-Ichiro Mori, MD, Ryuji Tanosaki, MD, Yuji Heike, MD, Kensei Tobinai, MD, Yoichi Takaue, MD, Takahiro Fukuda, MD

Blood (2010) 116 (21): 2318.

https://doi.org/10.1182/blood.V116.21.2318.2318

Published: 2010

Journal Articles

Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/− Total Body Irradiation for Older Patients (55 years and older): Results of the JSCT FB09 Study.

Naoyuki Uchida, MD, Michihiro Hidaka, MD, Toru Sakura, MD, Toshihiro Miyamoto, MD, PhD, Tomoaki Fujisaki, MD, PhD, Tetsuya Eto, MD, PhD, Yoshinobu Maeda, MD, PhD, Kenji Fukuno, MD, PhD, Kana Matsumoto, PhD, Kunihiko Morita, PhD, Junji Kishimoto, PhD, Takahiro Fukuda, MD, PhD, Takanori Teshima, MD, PhD, Shuichi Taniguchi, MD, PhD, Shin-Ichiro Mori, MD, Mine Harada, MD, PhD

Blood (2010) 116 (21): 3477.

https://doi.org/10.1182/blood.V116.21.3477.3477

Published: 2010

Journal Articles

Renal Complications after Busulfan-Based Reduced-Intensity Stem Cell Transplantation in 286 Patients with Hematological Disorders.

Kimikazu Yakushijin, Takahiro Fukuda, Yoshitaka Asakura, Saiko Kurosawa, Nobuhiro Hiramoto, Daisuke Nakamura, Kohei Tada, Masaaki Nishinohara, Akihito Hagiwara, Niina Ueno, Yutaro Kamiyama, Masakazu Mori, Sung-Won Kim, Shin-ichiro Mori, Ryuji Tanosaki, Yuji Heike, Yoichi Takaue

Blood (2009) 114 (22): 3353.

https://doi.org/10.1182/blood.V114.22.3353.3353

Published: 2009

Journal Articles

Long-Term Outcome of ATL Patients Who Underwent Reduced-Intensity Stem Cell Transplantation (RIST): Suggested Potent Graft-Versus-ATL and HTLV-1 Effects.

Ryuji Tanosaki, Kimikazu Yakushijin, Yoshitaka Asakura, Saiko Kurosawa, Nobuhiro Hiramoto, Masakazu Mori, Takahiro Fukuda, Sung-Won Kim, Shin-ichiro Mori, Yuji Heike, Kensei Tobinai, Yoichi Takaue

Blood (2009) 114 (22): 3370.

https://doi.org/10.1182/blood.V114.22.3370.3370

Published: 2009

Journal Articles

Obesity Is Associated with An Increased Risk of Infectious Diseases after Unrelated Bone Marrow Transplantation

Shigeo Fuji, MD, Sung-Won Kim, MD, Ken-ichi Yoshimura, PhD, Hideki Akiyama, MD, Shin-ichiro Okamoto, MD, Hiroshi Sao, MD, Junko Takita, MD, Naoki Kobayashi, MD, Shin-ichiro Mori, MD

Blood (2008) 112 (11): 4346.

https://doi.org/10.1182/blood.V112.11.4346.4346

Published: 2008

Journal Articles

“Painless” Bone Marrow Aspiration by Slow Suctioning Does Not Affect Peripheral Blood Contamination of the Specimen: Randomized Prospective Crossover Trials

Yuki Asano-Mori, MD, PhD, Shin-ichiro Mori, MD, Toshimitsu Ueki, MD, Miwa Sakai, MD, Takuya Yamashita, MD, PhD, Kazuteru Ohashi, MD, PhD, Hideki Akiyama, MD, PhD, Hisashi Sakamaki, MD, PhD

Blood (2008) 112 (11): 4683.

https://doi.org/10.1182/blood.V112.11.4683.4683

Published: 2008

Journal Articles

Cytoreductive Regimen Containing Ranimustine (MCNU),Carboplatin, Etoposide and Cyclophosphamide (MCEC) Before Autologous Peripheral Blood Stem Cell Transplantation for Relapsed or Refractory Lymphoma

Yoshitaka Asakura, MD, Ryuji Tanosaki, MD, Sung-Won Kim, MD, Teruhisa Azuma, MD, Saiko Kurosawa, MD, Kimikazu Yakushijin, MD, Dai Maruyama, MD, Shin-ichiro Mori, MD, Takahiro Fukuda, MD, Takashi Watanabe, MD, Yukio Kobayashi, MD, PhD, Kensei Tobinai, MD, PhD, Yoichi Takaue, MD

Blood (2008) 112 (11): 4448.

https://doi.org/10.1182/blood.V112.11.4448.4448

Published: 2008

Journal Articles

Effects of Recipients’ Body Weight and Total Nucleated Cell Dose on Outcomes of Unrelated Bone Marrow Transplantation: Analysis of Clinical Data of 3,114 Leukemia Patients from the Database of the Japan Marrow Donor Program

Takuya Yamashita, Hideki Akiyama, Kazuteru Ohashi, Makoto Onizuka, Shin-ichiro Mori, Hiroshi Sao, Koichi Miyamura, Hisashi Sakamaki

Blood (2008) 112 (11): 3010.

https://doi.org/10.1182/blood.V112.11.3010.3010

Published: 2008

Journal Articles

Outcomes among Patients with Relapsed Malignant Lymphoma after Allogeneic Hematopoietic Stem Cell Transplantation

Ryuji Tanosaki, MD, Sung-Won Kim, MD, Yoshitaka Asakura, MD, Saiko Kurosawa, MD, Kimikazu Yakushijin, MD, Teruhisa Azuma, MD, Shin-ichiro Mori, MD, Takahiro Fukuda, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2008) 112 (11): 4296.

https://doi.org/10.1182/blood.V112.11.4296.4296

Published: 2008

Journal Articles

Randomized Phase II Trial Comparing Cyclosporine (CSP) and Tacrolimus (TAC) for Methotrexate (MTX)-Free Graft-Versus-Host Disease (GVHD) Prophylaxis after Allogeneic Transplantation from a Matched Related Donor (MRD) with a Reduced-Intensity Regimen Containing Cladribine and Busulfan

Sung-Won Kim, MD, Takahiro Fukuda, MD, Shotaro Hagiwara, MD, Tsunehiko Komatsu, MD, Tetsuya Goto, MD, Yasunori Ueda, M.D., Toshiro Ito, MD, Masayuki Hino, MD, Kazutaka Sunami, MD, Ryuji Tanosaki, MD, Shin-ichiro Mori, MD, Masahiro Kami, MD, Kinuko Tajima, Yoichi Takaue, MD

Blood (2008) 112 (11): 1170.

https://doi.org/10.1182/blood.V112.11.1170.1170

Published: 2008

Journal Articles

Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.

Shigeo Fuji, MD, Sung-Won Kim, MD, Takahiro Fukuda, MD, Shin-ichiro Mori, MD, Satoshi Yamasaki, MD, Yuriko Morita-Hoshi, MD, Fusako Ohara-Waki, MD, Yuji Heike, MD, Kensei Tobinai, MD, Ryuji Tanosaki, MD, Yoichi Takaue, MD

Blood (2007) 110 (11): 1968.

https://doi.org/10.1182/blood.V110.11.1968.1968

Published: 2007

Journal Articles

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Bungo Saito, MD, Takahiro Fukuda, MD, Hiroki Yokoyama, MD, Saiko Kurosawa, MD, Toshihiro Takahashi, MD, Shigeo Fuji, MD, Noriko Takahashi, Kinuko Tajima, PhD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Yoichi Takaue, MD, Yuji Heike, MD

Blood (2007) 110 (11): 2009.

https://doi.org/10.1182/blood.V110.11.2009.2009

Published: 2007

Journal Articles

Effect of Interventions for Relapse or Progression Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience of 93 Patients.

Saiko Kurosawa, MD, Takahiro Fukuda, MD, Shin-ichiro Mori, MD, Sung-Won Kim, MD, Shigeo Fuji, MD, Bungo Saito, MD, Toshihiro Takahashi, MD, Hiroki Yokoyama, MD, Kinuko Tajima, Ryuji Tanosaki, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2007) 110 (11): 1648.

https://doi.org/10.1182/blood.V110.11.1648.1648

Published: 2007

Journal Articles

Similar Background of Graft-Versus-Host Disease (GVHD) Following Allogeneic Blood and Marrow Transplantation (Tx) in Korean and Japanese Populations Allows a Uniform Foundation To Perform Large-Scale Clinical Studies in the Region.

Blood (2007) 110 (11): 5007.

https://doi.org/10.1182/blood.V110.11.5007.5007

Published: 2007

NARROW

Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1 / FLT3 -ITD Genotypes in Patients with Acute Myeloid Leukemia

Late Relapse After Allogeneic Hematopoietic Cell Transplantation For Hematological Malignancies: A Nationwide Retrospective Study From The Late Complications and Quality-Of-Life Working Group Of The Japan Society For Hematopoietic Cell Transplantation

Pharmacokinetics for Once-Daily Modified Release Formulation Tacrolimus Hydrate in Unrelated Hematopoietic Stem Cell Transplantation.

Immunochromatography Method Was Useful in Prompt Diagnosis of Potentially Fatal Norovirus Gastroenteritis After Hematopoietic Stem Cell Transplantation

Alloimmune Effect May Improve Survival of De Novo Myelodysplastic Syndrome After allogeneic hematopoietic cell transplantaion: A Single Center Analysis of 115 Patients

A Novel Enumeration Method for Hematopoietic Progenitor Cells in Collecting Peripheral Blood Stem Cell for Transplantation

Engraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk Patients

Prospective Multicenter Phase II Study of Myeloablative Conditioning Consisted of Intravenous Busulfan and Fludarabine +/− Total Body Irradiation for Older Patients (55 years and older): Results of the JSCT FB09 Study.

Renal Complications after Busulfan-Based Reduced-Intensity Stem Cell Transplantation in 286 Patients with Hematological Disorders.

Long-Term Outcome of ATL Patients Who Underwent Reduced-Intensity Stem Cell Transplantation (RIST): Suggested Potent Graft-Versus-ATL and HTLV-1 Effects.

Obesity Is Associated with An Increased Risk of Infectious Diseases after Unrelated Bone Marrow Transplantation

“Painless” Bone Marrow Aspiration by Slow Suctioning Does Not Affect Peripheral Blood Contamination of the Specimen: Randomized Prospective Crossover Trials

Cytoreductive Regimen Containing Ranimustine (MCNU),Carboplatin, Etoposide and Cyclophosphamide (MCEC) Before Autologous Peripheral Blood Stem Cell Transplantation for Relapsed or Refractory Lymphoma

Effects of Recipients’ Body Weight and Total Nucleated Cell Dose on Outcomes of Unrelated Bone Marrow Transplantation: Analysis of Clinical Data of 3,114 Leukemia Patients from the Database of the Japan Marrow Donor Program

Outcomes among Patients with Relapsed Malignant Lymphoma after Allogeneic Hematopoietic Stem Cell Transplantation

Randomized Phase II Trial Comparing Cyclosporine (CSP) and Tacrolimus (TAC) for Methotrexate (MTX)-Free Graft-Versus-Host Disease (GVHD) Prophylaxis after Allogeneic Transplantation from a Matched Related Donor (MRD) with a Reduced-Intensity Regimen Containing Cladribine and Busulfan

Pre-Engraftment Serum C-Reactive Protein (CRP) Value as a Predictor of Acute Graft-Versus-Host Disease and Non-Relapse Mortality.

Impact of T-Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen.

Effect of Interventions for Relapse or Progression Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience of 93 Patients.

Similar Background of Graft-Versus-Host Disease (GVHD) Following Allogeneic Blood and Marrow Transplantation (Tx) in Korean and Japanese Populations Allows a Uniform Foundation To Perform Large-Scale Clinical Studies in the Region.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only